Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan and ET-1 Constriction in Hypertensive Postmenopausal Women
NCT03371823Phase 4Terminated
- Sponsor
- University of Delaware
- Start
- Sep 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of losartan in hypertension (HTN), sponsored by University of Delaware. Started Sep 2017; status: terminated.
02
Drugs
losartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03371823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03371823.